Investing in the
Investing in the
Science of Vitality
Science of Vitality
We back the founders and science turning longevity from aspiration into medicine.
darkMatter Longevity Fund invests in the companies building the next generation of human health. We partner with founders whose science is sound, whose vision is bold, and whose work extends vitality itself.
darkMatter Longevity Fund invests in the companies building the next generation of human health. We partner with founders whose science is sound, whose vision is bold, and whose work extends vitality itself.
Personalized Medicine
Five pillars of human vitality.
Pre-seed to Phase II.
Bioscience Explosion
CRISPR therapies are approved. 15+ senolytic compounds are in human trials. Core aging processes are now pharmacologically modifiable. The science is no longer theoretical — it's clinical.
Bioscience Explosion
CRISPR therapies are approved. 15+ senolytic compounds are in human trials. Core aging processes are now pharmacologically modifiable. The science is no longer theoretical — it's clinical.
Unprecedented Data
AlphaFold has mapped 200M+ protein structures. New biomarkers give us continuous, measurable signals about biological age, risk, and response. We can now design drugs against targets that were invisible five years ago.
Unprecedented Data
AlphaFold has mapped 200M+ protein structures. New biomarkers give us continuous, measurable signals about biological age, risk, and response. We can now design drugs against targets that were invisible five years ago.
Leaps in Demand
The global longevity market is projected to exceed $600B by 2030. The gap between what science can do and what patients can access is where value lives.
Leaps in Demand
The global longevity market is projected to exceed $600B by 2030. The gap between what science can do and what patients can access is where value lives.
Entrepreneurial Talent
A path to IND that once cost $10-15M now runs $3-5M. Repeat founders from software are bringing their company-building craft to longevity. The barriers to building in biotech have never been lower.
Entrepreneurial Talent
A path to IND that once cost $10-15M now runs $3-5M. Repeat founders from software are bringing their company-building craft to longevity. The barriers to building in biotech have never been lower.
Bioscience Explosion
CRISPR therapies are approved. 15+ senolytic compounds are in human trials. Core aging processes are now pharmacologically modifiable. The science is no longer theoretical — it's clinical.
Leaps in Demand
The global longevity market is projected to exceed $600B by 2030. The gap between what science can do and what patients can access is where value lives.
Unprecedented Data
AlphaFold has mapped 200M+ protein structures. New biomarkers give us continuous, measurable signals about biological age, risk, and response. We can now design drugs against targets that were invisible five years ago.
Entrepreneurial Talent
A path to IND that once cost $10-15M now runs $3-5M. Repeat founders from software are bringing their company-building craft to longevity. The barriers to building in biotech have never been lower.
About darkMatter
Built for
Built for
This Moment
This Moment
Innovate
Cutting Edge Access
Trusted networks at the intersection of Silicon Valley, bioscience research, and company building. Our Exosphere network spans 350+ alumni from 50+ countries.
Longevity
Science
Innovate
Cutting Edge Access
Trusted networks at the intersection of Silicon Valley, bioscience research, and company building. Our Exosphere network spans 350+ alumni from 50+ countries.
Longevity
Science
Innovate
Cutting Edge Access
Trusted networks at the intersection of Silicon Valley, bioscience research, and company building. Our Exosphere network spans 350+ alumni from 50+ countries.
Longevity
Science
Trust
Profound Discipline
Deep domain experience paired with the entrepreneurial energy of a modern venture firm. $70M+ deployed across 50+ companies in 16 countries.
Trust By Design
Rigour
Trust
Profound Discipline
Deep domain experience paired with the entrepreneurial energy of a modern venture firm. $70M+ deployed across 50+ companies in 16 countries.
Trust By Design
Rigour
Trust
Profound Discipline
Deep domain experience paired with the entrepreneurial energy of a modern venture firm. $70M+ deployed across 50+ companies in 16 countries.
Trust By Design
Rigour
Scale
A Track Record That Speaks
Investing partners whose outcomes are several standard deviations above venture in general — including biotech and health. 100M+ users reached across consumer products.
Discovery
Growth
Scale
A Track Record That Speaks
Investing partners whose outcomes are several standard deviations above venture in general — including biotech and health. 100M+ users reached across consumer products.
Discovery
Growth
Scale
A Track Record That Speaks
Investing partners whose outcomes are several standard deviations above venture in general — including biotech and health. 100M+ users reached across consumer products.
Discovery
Growth
darkMatter Longevity Fund
Meet the Team
Behind the Science
A team that speaks both lab and late-stage capital, combining scientific depth with investment discipline.
darkMatter Longevity Fund
Meet the Team
Behind the Science
A team that speaks both lab and late-stage capital, combining scientific depth with investment discipline.
darkMatter Longevity Fund
Meet the Team
Behind the Science
A team that speaks both lab and late-stage capital, combining
scientific depth with investment discipline.
